S. Bibert

Discipline

Histoire, Philosophie et Sociologie des sciences (1) Economies et finances (1)

Type de document

Articles (16) Colloques et conférences (2)

Co-auteur

Date

Source

Mot-clé

Patients (13) Patients (13) association (11) Treatment (11) Social groups (11) infection (9) Infection (9) gène (8) Genes (8) risque (7) Hepatitis C virus (7) Risk (7) Single nucleotide polymorphisms (7) Influence (7) thérapie (6) Therapeutics (6) Liver (6) Susceptibility (6) Development (5) Methods (5) Hepatitis C (5) Methods (5) Models (5) cohorte (5) spectacle (4) protéine (4) organe (4) maladie (4) taux (4) Serum (4)

Documents écrit par S. Bibert (18) | parle de S. Bibert (0)

Herpes simplex encephalitis in adult patients with MASP-2 deficiency.
S. Bibert et al.
IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.
A. Wójtowicz et al.
Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing.
F. About et al. (2019)
Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms.
S. Bibert et al. (2017)
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.
N. Saigi-Morgui et al. (2016)
Reply to Cunha et al.
A. Wójtowicz et al. (2015)
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.
A. Wójtowicz et al. (2015)
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant.
A. Wójtowicz et al. (2015)
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation.
O. Manuel et al. (2015)
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
E. Terczyńska-Dyla et al. (2014)
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.
S. Bibert et al. (2013)
Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development.
C.M. Lange et al. (2013)
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
E. Patin et al.
A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C.
C.M. Lange et al. (2012)
Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms.
M. Lagging et al. (2011)
IL28B polymorphism is significantly correlated with ifn anti-viral effectiveness already on first day of pegylated interferon-alpha and ribavirin therapy of chronic HCV infection
A. Neumann et al. (2010)
IFN stimulated gene expression in the liver is a better predictor of treatment response in chronic hepatitis c than the IL28b (IFN lambda 3) genotype
M.T. Dill et al. (2010)
A novel family of transmembrane proteins interacting with beta subunits of the Na,K-ATPase
S. Gorokhova et al.